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CASE REPORT Open Access
Association of the mtDNA m.4171C>A/MT-ND1
mutation with both optic neuropathy and
bilateral brainstem lesions
Chiara La Morgia1,2*†, Leonardo Caporali1†, Francesca Gandini3, Anna Olivieri3, Francesco Toni4, Stefania Nassetti1,
Daniela Brunetto1,2, Carlotta Stipa1,2, Cristina Scaduto1,2, Antonia Parmeggiani1,2, Caterina Tonon5, Raffaele Lodi5,
Antonio Torroni3 and Valerio Carelli1,2
Abstract
Background: An increasing number of mitochondrial DNA (mtDNA) mutations, mainly in complex I genes, have
been associated with variably overlapping phenotypes of Leber’s hereditary optic neuropathy (LHON),
mitochondrial encephalomyopathy with stroke-like episodes (MELAS) and Leigh syndrome (LS). We here describe
the first case in which the m.4171C>A/MT-ND1 mutation, previously reported only in association with LHON, leads
also to a Leigh-like phenotype.
Case presentation: A 16-year-old male suffered subacute visual loss and recurrent vomiting and vertigo associated
with bilateral brainstem lesions affecting the vestibular nuclei. His mother and one sister also presented subacute
visual loss compatible with LHON. Sequencing of the entire mtDNA revealed the homoplasmic m.4171C>A/MT-ND1
mutation, previously associated with pure LHON, on a haplogroup H background. Three additional non-synonymous
homoplasmic transitions affecting ND2 (m.4705T>C/MT-ND2 and m.5263C>T/MT-ND2) and ND6 (m.14180T>C/MT-ND6)
subunits, well recognized as polymorphisms in other mtDNA haplogroups but never found on the haplogroup H
background, were also present.
Conclusion: This case widens the phenotypic expression of the rare m.4171C>A/MT-ND1 LHON mutation, which
may also lead to Leigh-like brainstem lesions, and indicates that the co-occurrence of other ND non-synonymous
variants, found outside of their usual mtDNA backgrounds, may have increased the pathogenic potential of the
primary LHON mutation.
Keywords: Mitochondrial disease, Vision loss, Bilateral brainstem lesions, LHON, mtDNA mutation, Leigh
syndrome, Idebenone
Background
Leber’s hereditary optic neuropathy (LHON), a mater-
nally inherited blinding disorder, is associated with three
common mitochondrial DNA (mtDNA) point mutations
affecting complex I (m.3460G>A/MT-ND1, m.11778G>A/
MT-ND4, m.14484T>C/MT-ND6) in 90% of cases [1]. A
wider range of mtDNA mutations, again mainly in
complex I genes (MT-ND1, MT-ND5 and MT-ND6;
http://www.mitomap.org/), have been instead associated
with variably overlapping phenotypes of LHON, mito-
chondrial encephalomyopathy with stroke-like episodes
(MELAS) and Leigh syndrome (LS) [2]. Occasionally, the
latter manifestations have been described also with the
common LHON mutations [3]. A recent study, reviewing
the neuroradiological features of a large cohort of LS pa-
tients, suggested that bilateral brainstem lesions are more
typical of mtDNA-related complex I deficiency, in most
cases with a concurrent striatal involvement [4]. We
have recently reported one such case with brainstem
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lesions without striatal involvement associated with the
rare m.3890G>A/MT-ND1 mutation [5].
We here describe for the first time a maternal lineage
carrying the homoplasmic rare m.4171C>A/MT-ND1 mu-
tation, previously associated only with pure LHON, whose
proband in addition to optic neuropathy presented acute
onset of vomiting, vertigo and nystagmus in associ-
ation with bilateral brainstem lesions affecting vestibu-
lar nuclei.
Case presentation
A 16-year-old male of Belarusian origin was referred for the
acute onset of vomiting and vertigo. Family history was
relevant for the recurrence of subacute visual loss and optic
atrophy in the proband’s mother (at age 17) and one sister
(at age 9) (Figure 1A), both reporting a spontaneous visual
recovery.
The proband suffered subacute loss of vision bilaterally at
age 12, after a febrile illness, without recovery. We observed
this patient at age 16, three months after the acute onset of
recurrent vomiting and vertigo. Neurological examination
at admission showed horizontal nystagmus, segmental and
parcellar myoclonic jerks at upper and lower limbs, slight
dysmetria at the right upper limb, weak deep tendon re-
flexes, positive Romberg sign and mild ataxic gait.
Brain magnetic resonance imaging (MRI) revealed bi-
lateral lesions of the brainstem involving the vestibular
nuclei (Figure 1B, upper row). Moreover, MRI showed atro-
phy of the optic nerves bilaterally with hyperintense signal
in the T2-weighted images with enhancement after gadolin-
ium administration (not shown). Serum lactic acid after
standardized exercise was abnormally elevated (3.1 mM,
n.v. 1–2 mM). Ophthalmologic evaluation showed bi-
lateral temporal pallor, visual acuity (a measure of central
Figure 1 Pedigree, brain MRI and ophthalmologic findings. A: pedigree with affected individuals (blackened symbols) and individuals for
which DNA analysis was performed (DNA). B: Axial FLAIR T2-weighted brain MRI at baseline showing bilateral vestibular nuclei lesions (upper row,
arrows), their disappearance at follow-up (middle row) in association with the appearance of a lesion involving the left inferior colliculus (lower
row, arrow). C: Humphrey visual fields (total deviation) of both eyes at baseline (T0) and follow-up (T1). A slight increase in mean deviation (MD)
from T0 to T1 is reflected by shrinkage of the scotoma, with some improvement of the peripheral field sensitivity. D: optical coherence tomography
showing diffuse optic atrophy in both eyes, with some preservation of the nasal quadrant in OS.
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vision function) was 0.2 bilaterally and visual fields dem-
onstrated bilateral cecocentral scotomas, more severe in
OD (Figure 1C). Optical coherence tomography evaluating
retinal nerve fiber layer thickness showed bilateral diffuse
optic atrophy with nasal sparing (Figure 1D). Cognitive
functions assessment was normal, as well as audiometry
and electroencephalography. A therapy with high dose
idebenone (540 mg/day) was started with improvement
of vomiting and vertigo and visual function after about
two months.
Follow-up evaluation after eight months from therapy
start showed an improvement of visual acuity in OS (0.4)
and a slight improvement of visual field defect in both eyes
(mean deviation from −18 to −15 in OD and −16 to −15
in OS) (Figure 1C). Lactic acid after exercise was slightly
worse compared to the baseline evaluation (3.9 mM), but
the patient reported intense physical training in the previ-
ous month. Brain MRI follow-up showed a complete reso-
lution of vestibular nuclei lesions (Figure 1B, middle row),
and the appearance of a new lesion affecting the left tuber-
culus quadrigeminus (Figure 1B, lower row).
We first surveyed the proband for the three common
LHON mutations, which were absent, then his entire
mtDNA was sequenced (GenBank accession number
KF927040). The mitogenome was characterized by
the diagnostic mutational motif of haplogroup H (http://
www.phylotree.org/). In addition, it also harbored the
m.4171C>A/MT-ND1 transversion relative to the revised
Cambridge Reference Sequence, [6] which causes the
p.L289M amino acid change and was previously reported
in association only with a “pure” LHON phenotype, and
four transitions: the synonymous m.3798C>T/MT-ND1
and the three non-synonymous changes m.4705T>C/MT-
ND2, m.5263C>T/MT-ND2 and m.14180T>C/MT-ND6,
all affecting complex I. Restriction fragment length poly-
morphism (RFLP) analysis of the proband, one un-
affected sister and the mother (Figure 1A) on DNA
extracted from both blood cells and urinary epithelium
sediment confirmed that the m.4171C>A/MT-ND1 trans-
version was consistently homoplasmic. As for the three
non-synonymous changes, they cause the amino acid sub-
stitutions p.M79T and p.A265V in ND2, and p.Y165C in
ND6, but they all have been reported as diagnostic markers
for some ancient continent-specific haplogroups or sub-
haplogroups: m.4705T>C/MT-ND2 for sub-haplogroup
F1b1a1a1, m.5263C>T/MT-ND2 for sub-haplogroups V1a1,
U5a1d1, F4, B4a1c3a, M29a, M2b1b, G1a1a3, L2a5, and
m.14180T>C/MT-ND6 for sub-haplogroups T2b26, D4b
1a1a, L2a1l2a (http://www.phylotree.org/). Finally, all three
amino acid residues are moderately conserved [7] and in
silico analysis predicted a possibly pathogenic role for the
m.14180T>C/MT-ND6 and m.4705T>C/MT-ND2 variants
(Table 1). RFLP survey of these three mutations confirmed
that they were homoplasmic in the mother and one
unaffected sister. We also extended the conservation ana-
lysis on the protein regions surrounding these polymor-
phisms, according to a previously established method [8].
All three changes had an invariant amino acid within four
contiguous amino acidic positions (+4/−4 aa) and they hit a
protein region with a local conservation higher than global
conservation of the protein subunit (Table 1). Finally, we
compared the mtDNA background of our proband with
those of the previous cases reported with the m.4171C>A/
MT-ND1 transversion (Table 2) [8-11]. Only one pedigree
from China, characterized by almost complete penetrance,
displayed the co-occurrence of possibly synergistic complex
I variants [11].
Discussion and conclusions
We report the association of the m.4171C>A/MT-ND1
LHON mutation with bilateral lesions of the brainstem
resembling Leigh syndrome associated with acute onset
of vomiting and vertigo, in addition to subacute bilateral
loss of central vision, typical of LHON. This case ex-
tends the clinical features associated with this rare muta-
tion, previously reported only in association with pure
LHON, [8-11] and reissues the unexplained wide vari-
ability in severity of homoplasmic mtDNA mutations
[2]. This family is the sixth maternal lineage carrying this
rare mutation, the second on a European mtDNA back-
ground. Non-synonymous mtDNA variants, in particular
those affecting complex I and III subunit genes, have
been implicated in both variable penetrance and severity
of LHON clinical expression [7,12]. For example, one
LHON family from China carrying the m.4171C>A/MT-
ND1 and the m.14841A > G/MT-ND6 variant, showed
an almost complete penetrance, unusual for LHON [11].
Our genetic analysis also supports the possible role of
supplementary mtDNA variants in increasing disease
severity leading to the overlapping phenotype of LHON
and LS. In fact, our patient’s mitogenome harbored, in
addition to the m.4171C>A/MT-ND1 pathogenic muta-
tion, three non-synonymous variants in ND subunits of
complex I. These polymorphic variants are reported in a
large variety of sub-haplogroups, but never within the
context of haplogroup H, as in our patient. Increasing
evidence shows that some non-synonymous variants
may be tolerated in certain haplogroups and exert a dif-
ferent functional effect in others. For example, the non-
synonymous variant m.3394T>C/MT-ND1 (Y30H) has
been associated with LHON in the Asian B4c and F1
haplogroup backgrounds, whereas it is enriched as a com-
mon variant on the M9 background in Tibet and the C4a4
background on the Indian Deccan Plateau, exerting an
adaptive role to high-altitude in Tibetan and Indian popula-
tions, respectively [13]. It is increasingly recognized that
genetic variation characterizing mtDNA haplogroups exerts
slight but significant functional differences, as demonstrated
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by studies on cybrid cell lines carrying mtDNA from
control subjects with different haplogroups [14]. Thus,
the peculiar coexistence of the three variants with the
m.4171C>A/MT-ND1 mutation may explain the occur-
rence of the severe phenotype combining LHON and
brainstem lesions.
Furthermore, our proband is a male, whereas the other
two affected individuals in the same maternal lineage are
females and they both had a disease limited to the optic
nerve with spontaneous partial regression. This is com-
patible with the higher predisposition of males to LHON
and with the protective role of oestrogens in female mu-
tation carriers, as we recently demonstrated [15].
Idebenone administration coincided with a complete
resolution of the brainstem lesions and clinical symptoms,
with also a slight improvement in visual function. However,
this observation must be evaluated with caution given the
possibility of spontaneous visual recovery in LHON [1].
The patients from the previously reported Korean and
French families with the m.4171C>A/MT-ND1 were also
characterized by a high rate of spontaneous recovery of
visual acuity [8,9]. Furthermore, we previously observed
another case resembling our proband who also presented
spontaneous regression of the vestibular nuclei lesions be-
fore idebenone administration [5]. Interestingly, this pa-
tient had another rare mutation (m.3890G>A/MT-ND1)
affecting complex I, associated with both LHON and Leigh
phenotypes and presented in association with the regres-
sion of the vestibular nuclei abnormalities an involvement
of the inferior colliculi, identical to the unilateral in-
volvement the left inferior colliculus showed in our pa-
tient (Figure 1) [5].
In conclusion, homoplasmic mtDNA missense muta-
tions affecting ND subunits of complex I display a wide
variability in penetrance and clinical severity. The genetic
variation of mtDNA may contribute more substantially
than previously recognized to this variability, raising the
issue whether complete mtDNA sequencing should be car-
ried out routinely in these patients. Further nuclear DNA
variation and complex interactions with environmental fac-
tors are probably also relevant, but these are currently
poorly understood modulators.
Table 1 Conservation analysis of private variants and contiguous amino acid residues
Mutation m.4705T>C m.5263C>T m.14180T>C
Locus MT-ND2 MT-ND2 MT-ND6
AA change p.M79T p.A265V p.Y165C
Conservation (%)
Eukaryotes 25 (n = 161) 48 (n = 161) 36 (n = 124)
Vertebrates 3 (n = 126) 57 (n = 126) 54 (n = 83)
Mammals 41 (n = 95) 75 (n = 95) 26 (n = 43)
Prediction
Polyphen 2 Benign Benign Probably damaging
Provean Deleterious Neutral Deleterious
Contiguous amino acid conservation
Interval (−10/+10) 69-89 255-275 155-174
Local conservation (%) 68 83 69
Global conservation (%) 62 62 52
Nearest invariant position (−/+) −1/+2 −1/+1 −1/+4
Table 2 Non-synonymous nucleotide changes reported in published mtDNAs with m.4171C>A
Case Origin Haplogroup Non-synonymous nucleotide changesa Reference
1 Korea A 4171A, 4824, 8794, 14766 [9]
2 Korea A 4171A [9]
3 China n.a. n.a. [10]
4 China N9a1 4171A, 10203b,,12358, 14564b, 14766, 14841c, 15095 [11]
5 France J2b1 4171A, 4216, 7632c, 10398, 13708, 14766, 15257, 15452A, 15812 [8]
6 Belarus H 4171A, 4705b, 5263b, 14180b Present study
aThe non-synonymous nucleotide changes at nps 8860 (8860G) and 15326 (15326G), present in all sequenced samples, are not included because they are private
mutations of the reference sequence.7 In Italics, variants outside of their usual mtDNA background: b)variants in Complex I subunits or c)variants outside in
Complex I subunits.
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Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor of this journal.
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